Pharma Industry News
Printable Version   Email to a friend

U.S. Congress Threatens Canada's Prescription Drug Supply

OTTAWA, Ontario, Jan.10, 2007 /CNW Telbec/ - Canadian pharmacist and patients' groups  warned today that the federal government should act soon to protect Canada's  prescription drug supply following the introduction of a bulk-import bill in  the U.S Congress.      

"We have been raising concern about this potential catastrophe for the  Canadian drug supply system for months. It's now time for Minister Clement to  act," stated Dr. Jeff Poston of the Canadian Pharmacists Association. The Best Medicines Coalition agreed. "Patients can't afford this risk,"  said coalition chair Louise Binder. "Canadians need reassurance today that  prescription drugs will be there when we need them."       Canadian pharmacists and patients' groups have called on the Canadian  government to introduce an immediate and straightforward ban on the export,  both bulk and retail, of prescription drugs.      

In Washington, lawmakers of both houses of Congress said today they will  move ahead with legislation to allow prescription drug imports from Canada as  a way to address the high cost of prescription drugs in the U.S.      

"This is an unsustainable quick-fix for the made-in-America problem of  high U.S. drug costs," said Marc Kealey, CEO of the Ontario Pharmacists'  Association. Kealey added, "Congress is telling Americans it's okay to cherry-pick the  benefits of Canada's regulated drug system and solve a domestic U.S. problem  on the backs of Canadians. Canada cannot afford to become America's medicine  cabinet. That threatens the security of our own drug supply and the health and  well-being of Canadians." Poston noted that Canadians have built a drug supply and pricing  mechanism that meets Canadian needs. Buying drugs in Canada as a quick fix to  high U.S. drug prices is not a solution. U.S. lawmakers should design a system  that responds to the needs of Americans instead of jeopardizing Canada's drug  supply.      

Canada's health minister, the Honourable Tony Clement, remains silent on  the issue. His staff have previously said the government does not expect U.S.  changes to impact Canada's drug supply. An independent study by the University of Texas at Austin shows that  Canada's current drug supply would only last for 38 days if Americans are  allowed to buy Canadian medicine in bulk.      

"This is a clear threat to the Canadian drug supply," said Kealey. "We  need to hear from the federal government straight away what they plan to do.  This is a problem that can be prevented. The government needs to act now."        

For further information: Louise Crandall, Canadian Pharmacists  Association, (613) 523-7877; Mary Ann Cedrone, Ontario Pharmacists'  Association, (416) 441-0788; Paulette Eddy, Best Medicines Coalition, (416)  622-3893

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


MedNotes
Latest FDA Drug Alerts
October 9, 2008
Audience: Pediatric and primary healthcare professionals, consumers [Posted 10/09/2008] FDA notified healthcare professionals and...
October 7, 2008
Audience: Pulmonary care health professionals and patients[UPDATE 10/07/2008] FDA informed healthcare professionals that FDA has...
October 3, 2008
Audience: Healthcare professionals, consumers [Posted 10/03/2008] FDA notified healthcare professionals of a Class I Recall of...
October 2, 2008
Audience: Physical medicine and rehabilitation specialists, anesthesia healthcare professionals, hospital surgical service...
More...
Latest Drug Information Updates

Akten
Akten (lidocaine hydrochloride) Ophthalmic Gel is a topical, ocular anesthetic formulation for use in ocular procedures that require a topical anesthetic agent.

AdreView
AdreView is a diagnostic radiopharmaceutical agent indicated for use in the detection of rare neuroendocrine tumors in children and adults.

Sancuso
Sancuso (granisetron transdermal system) is an anti-emetic transdermal delivery system indicated for the control of nausea and vomiting in patients receiving moderately and/or highly nausea-inducing chemotherapy.

Nplate
Nplate (romiplostim) is a thrombopoietin mimetic peptibody for the treatment of thrombocytopenia in adult patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP).

Xenazine
Xenazine (tetrabenazine) is a selective and reversible centrally-acting dopamine depleting drug indicated for the treatment of chorea associated with Huntington's disease.

Cleviprex
Cleviprex is an intravenous, ultrashort-acting calcium channel blocker under development for the treatment of severely elevated blood pressure in the hospital setting when oral therapy is not feasible or desirable.

Stavzor
Stavzor is delayed-release valproic acid formulated in the EnteriCare enteric soft gelatin capsule delivery system designed to minimize GI adverse events. Stavzor is indicated for the treatment of manic episodes associated with bipolar disorder, adjunctive therapy in multiple seizure types (including epilepsy), and prophylaxis of migraine headaches.

Navstel
Navstel is a balanced salt ophthalmic solution for use as an intraocular irrigation during surgical procedures involving perfusion of the eye.

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

More...